Icon Key
![Document Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/jdfnj34f/icon_document-secondarysoft_v3.png)
Document
![Link Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/0epb3vdx/icon_link-secondarysoft.png)
External Site Link
![News Article Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/1tdfo24o/icon_news-secondarysoft_v2.png)
News Article
![Session Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/xn2cjump/icon_session-secondarysoft_v2.png)
Session
![Speaker Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/ocfhmt1b/icon_speaker-secondarysoft_v2.png)
Speaker
![Video Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/evshumxx/icon_video-secondarysoft_v2.png)
Video
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/wsabqegr/sessionicon-white.png)
Designing with the Patient in Mind: Amplifying the Patient Voice in Medicines Development and Approval
Bristol Myers Squibb | Health Technology Assessment International | Myeloma Patients Europe | The Michael J. Fox Foundation
May 12, 2022
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/0t0bvt1x/documenticon-white.png)
EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials
The European Patients’ Academy on Therapeutic Innovation
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/0t0bvt1x/documenticon-white.png)
EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes
The European Patients’ Academy on Therapeutic Innovation
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/0t0bvt1x/documenticon-white.png)
EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
The European Patients’ Academy on Therapeutic Innovation
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/0t0bvt1x/documenticon-white.png)
Giving Voice to the Often Voiceless: Advocate-led Research Creating Change
All.Can International | Bristol Myers Squibb | World Bladder Cancer Patient Coalition
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/0t0bvt1x/documenticon-white.png)
Mesothelioma Applied Research Foundation: One Pager + Services
Mesothelioma Applied Research Foundation
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/wsabqegr/sessionicon-white.png)
Moving Medicine Forward: Highlighting Humanity and Patient Experience in Clinical Trials
Bristol Myers Squibb | GRYT Health | National Institutes of Health | SparkCures
April 7, 2022
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/wsabqegr/sessionicon-white.png)
My Disease Does Not Define Me: Stigma and Perceptions of Chronic Illness
Bristol Myers Squibb | IFPA | PsorPhil
September 26, 2023
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/0t0bvt1x/documenticon-white.png)
Research Summaries: ASH 2021 MDS and AML for Patients
Aplastic Anemia and MDS International Foundation
![Resource Icon](https://s3.us-east-1.amazonaws.com/grytportal/conference/advexch/wsabqegr/sessionicon-white.png)
The Patient Voice & Patient-Focused Drug Development
Bristol Myers Squibb | Lupus and Allied Diseases Association, Inc. | Rare 2030 | Sant Joan de Déu Children's Hospital | The European Patients’ Academy on Therapeutic Innovation
July 23, 2020